81 related articles for article (PubMed ID: 24987058)
1. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study.
Franko A; Berti L; Guirguis A; Hennenlotter J; Wagner R; Scharpf MO; de Angelis MH; Wißmiller K; Lickert H; Stenzl A; Birkenfeld AL; Peter A; Häring HU; Lutz SZ; Heni M
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036464
[TBL] [Abstract][Full Text] [Related]
3. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.
Lafront C; Germain L; Campolina-Silva GH; Weidmann C; Berthiaume L; Hovington H; Brisson H; Jobin C; Frégeau-Proulx L; Cotau R; Gonthier K; Lacouture A; Caron P; Ménard C; Atallah C; Riopel J; Latulippe É; Bergeron A; Toren P; Guillemette C; Pelletier M; Fradet Y; Belleannée C; Pouliot F; Lacombe L; Lévesque É; Audet-Walsh É
J Clin Invest; 2024 Apr; ():. PubMed ID: 38625747
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer.
Li X; Bai Y; Feng K; Chu Z; Li H; Lin Z; Tian L
Pharmacol Rep; 2023 Dec; 75(6):1445-1453. PubMed ID: 37921966
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes.
Kong D; Sethi S; Li Y; Chen W; Sakr WA; Heath E; Sarkar FH
Prostate; 2015 Feb; 75(2):161-74. PubMed ID: 25307492
[TBL] [Abstract][Full Text] [Related]
6. Single luminal epithelial progenitors can generate prostate organoids in culture.
Chua CW; Shibata M; Lei M; Toivanen R; Barlow LJ; Bergren SK; Badani KK; McKiernan JM; Benson MC; Hibshoosh H; Shen MM
Nat Cell Biol; 2014 Oct; 16(10):951-61, 1-4. PubMed ID: 25241035
[TBL] [Abstract][Full Text] [Related]
7. Symmetrical and asymmetrical division analysis provides evidence for a hierarchy of prostate epithelial cell lineages.
Wang J; Zhu HH; Chu M; Liu Y; Zhang C; Liu G; Yang X; Yang R; Gao WQ
Nat Commun; 2014 Aug; 5():4758. PubMed ID: 25163637
[TBL] [Abstract][Full Text] [Related]
8. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Antonarakis ES; Lu C; Wang H; Luber B; Nakazawa M; Roeser JC; Chen Y; Mohammad TA; Chen Y; Fedor HL; Lotan TL; Zheng Q; De Marzo AM; Isaacs JT; Isaacs WB; Nadal R; Paller CJ; Denmeade SR; Carducci MA; Eisenberger MA; Luo J
N Engl J Med; 2014 Sep; 371(11):1028-38. PubMed ID: 25184630
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.
Diaz R; Nguewa PA; Redrado M; Manrique I; Calvo A
Prostate; 2015 Aug; 75(11):1137-49. PubMed ID: 25893276
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.
Schillace RV; Skinner AM; Pommier RF; O'Neill S; Muller PJ; Naik AM; Hansen JE; Pommier SJ
BMC Cancer; 2014 Sep; 14():733. PubMed ID: 25269750
[TBL] [Abstract][Full Text] [Related]
11. Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
Castillo V; Valenzuela R; Huidobro C; Contreras HR; Castellon EA
Int J Oncol; 2014 Sep; 45(3):985-94. PubMed ID: 24990514
[TBL] [Abstract][Full Text] [Related]
12. Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer.
Kimura N; Yamada Y; Takayama KI; Fujimura T; Takahashi S; Kume H; Inoue S
Cancer Sci; 2018 Dec; 109(12):3840-3852. PubMed ID: 30238687
[TBL] [Abstract][Full Text] [Related]
13. TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.
Liang C; Wang S; Qin C; Bao M; Cheng G; Liu B; Shao P; Lv Q; Song N; Hua L; Gu M; Li J; Wang Z
Cell Death Dis; 2018 Feb; 9(2):155. PubMed ID: 29449534
[TBL] [Abstract][Full Text] [Related]
14. TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis.
Hatakeyama S
Trends Biochem Sci; 2017 Apr; 42(4):297-311. PubMed ID: 28118948
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Stem Cells: Biology and Treatment Implications.
Koukourakis IM; Platoni K; Kouloulias V; Arelaki S; Zygogianni A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834336
[TBL] [Abstract][Full Text] [Related]
16. The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future.
Zhou Y; Li T; Jia M; Dai R; Wang R
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108647
[TBL] [Abstract][Full Text] [Related]
17. CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer.
Qin XP; Lu QJ; Yang CH; Wang J; Chen JF; Liu K; Chen X; Zhou J; Pan YH; Li YH; Ren SC; Liu JM; Liu WP; Qian HJ; Yi XL; Lai CY; Qu LJ; Gao X; Xu YS; Chen Z; Zhuo YM
Front Oncol; 2022; 12():840950. PubMed ID: 35359369
[TBL] [Abstract][Full Text] [Related]
18. Microtubular TRIM36 E3 Ubiquitin Ligase in Embryonic Development and Spermatogenesis.
Mascaro M; Lages I; Meroni G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053362
[TBL] [Abstract][Full Text] [Related]
19. Understanding and targeting prostate cancer cell heterogeneity and plasticity.
Tang DG
Semin Cancer Biol; 2022 Jul; 82():68-93. PubMed ID: 34844845
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
